Topical and Subconjunctival Bevacizumab for Corneal Neovascularization in an Experimental Rat Model

Publisher： Karger

E-ISSN： 1423-0259|48|3|118-123

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.48, Iss.3, 2012-04, pp. : 118-123

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of Corneal Neovascularization: Comparison of Different Doses of Subconjunctival Bevacizumab with Its Topical Form in Experimental Rats

By  

Ophthalmic Research, Vol. 46, Iss. 1, 2011-01 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

Effect of Subconjunctival and Intraocular Bevacizumab Injections on Corneal Neovascularization in a Mouse Model

By Avisar Inbal   Weinberger Dov   Kremer Israel  

Current Eye Research, Vol. 35, Iss. 2, 2010-02 ,pp. : 108-115

Informa Healthcare

Access to resources Recommend Favorite

Prevention and Treatment of Corneal Neovascularization: Comparison of Different Doses of Subconjunctival Bevacizumab with Corticosteroid in Experimental Rats

By  

Ophthalmic Research, Vol. 42, Iss. 2, 2009-06 ,pp. : 90-95

Karger

Access to resources Recommend Favorite

The Impact of Subconjuctivally Injected EGF and VEGF Inhibitors on Experimental Corneal Neovascularization in Rat Model

By Sener Ender   Yuksel Nusen   Yildiz Demir Kursat   Yilmaz Bulent   Ozdemir Ozdemir   Caglar Yusuf   Degirmenci Esra  

Current Eye Research, Vol. 36, Iss. 11, 2011-11 ,pp. : 1005-1013

Informa Healthcare

Access to resources Recommend Favorite

Semaphorin 7A Promotes Angiogenesis in an Experimental Corneal Neovascularization Model

By Ghanem Ramon C.   Han Kyu Yeon   Rojas Juan   Ozturk Okan   Kim David J.   Jain Sandeep   Chang Jin-Hong   Azar Dimitri T.  

Current Eye Research, Vol. 36, Iss. 11, 2011-11 ,pp. : 989-996

Informa Healthcare

Access to resources Recommend Favorite